Drugs / AV-1980R
last change Jun 2026 re-read 3 minutes ago

AV-1980R

Vaccine

Developed for
Alzheimer disease
Investigated by
Institute for Molecular Medicine · National Institute on Aging (NIA)

Trials 1

202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07158905 Jun 2026 → Jun 2029 expected Alzheimer disease Institute for Molecular Medicine Recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AV-1980R ClinicalTrials.gov intervention name — accepted as the source's own label NCT07158905 ↗
Modality Vaccine “an investigational vaccine targeting tau protein” NCT07158905 ↗
Route Intramuscular “intramuscularly” NCT07158905 ↗